Presently, it has been confirmed that ZFPM2-AS1, LINC01224, and LUCAT1 possess differing expression levels in liver cancer tissues and are involved in multiple processes promoting hepatocarcinogenesis, including enhancing proliferation of tumor cells, anti-apoptosis, improving the migration ability of cancer cells, and strengthening the invasiveness of cancer cells (He et al., 2020; Liu et al., 2020). Here, ZFPM2 is linked to neoplasm.